Ernexa Therapeutics Inc. Goodwill
Ernexa Therapeutics Inc. (ERNA) had Goodwill of $2.04 million as of 2025-12-31, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-08-06
- 2025-12-31: Goodwill $2.04M.
- 2025-09-30: Goodwill $2.04M.
- 2025-06-30: Goodwill $2.04M.
- 2025-03-31: Goodwill $2.04M.
| Period end | Goodwill | Goodwill as first filed |
|---|---|---|
| 2025-12-31 | $2.04M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $2.04M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $2.04M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $2.04M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $2.04M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $2.04M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.04M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $2.04M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $2.04M 10-K · filed 2025-03-12 | |
| 2023-09-30 | $2.04M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.04M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $2.04M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.04M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $2.04M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.04M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.04M 10-Q · filed 2022-07-01 | |
| 2021-12-31 | $2.04M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $2.04M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $2.04M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $2.04M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $2.04M 10-K/A · filed 2022-07-01 | $2.04M 10-Q · filed 2021-05-17 |
| 2019-12-31 | $696.00K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $687.00K 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $695.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $681.00K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $667.00K 10-K · filed 2020-03-19 | |
| 2018-09-30 | $976.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $955.00K 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $978.00K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $1.00M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $1.01M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $968.00K 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $946.00K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $937.00K 10-K · filed 2018-03-09 | |
| 2016-09-30 | $959.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $973.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $972.00K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $909.00K 10-K · filed 2017-03-09 | |
| 2015-09-30 | $940.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $1.02M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $997.00K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $1.08M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $1.13M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $1.18M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $1.14M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $1.18M 10-K · filed 2015-03-27 | |
| 2013-09-30 | $1.22M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $1.20M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $1.24M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $1.26M 10-K · filed 2014-03-31 | |
| 2012-09-30 | $1.28M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $1.23M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $1.26M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $1.24M 10-K · filed 2013-03-29 | |
| 2011-09-30 | $1.22M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.29M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $1.26M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |